MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

Long-term survival in oesophageal squamous cell carcinoma (ESCC) is related with pathological response after neoadjuvant chemoradiotherapy (NCRT) followed by surgery. However, effective biomarkers to predict the pathologic response are still lacking. Therefore, a systematic analysis focusing on gene...

Full description

Bibliographic Details
Main Authors: Qiyu Luo, Wenwu He, Tianqin Mao, Xuefeng Leng, Hong Wu, Wen Li, Xuyang Deng, Tingci Zhao, Ming Shi, Chuan Xu, Yongtao Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
oesophageal squamous cell carcinoma
MMS22L
bioinformatics analysis
neoadjuvant chemoradiotherapy
lymph node metastasis
migration
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.711642/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.711642/full

Similar Items